Comprehensive Tobacco Treatment for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.
Who Is on the Research Team?
Damon J Vidrine, Dr.PH
Principal Investigator
Moffitt Cancer Center
Jennifer Vidrine, PhD, MS
Principal Investigator
Moffitt Cancer Center
Are You a Good Fit for This Trial?
This trial is for English or Spanish speakers who currently smoke more than 5 cigarettes a day, are willing to try quitting within a week of joining, have smoked over 100 cigarettes in their lifetime, own a smartphone compatible with the study's app and have an email address. Pregnant or breastfeeding individuals, those on smoking cessation meds, enrolled in another cessation study or living with someone in this study can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 10-week supply of nicotine patches and lozenges, with weekly smartphone assessments
Follow-up
Participants are monitored for smoking abstinence and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Counceling
- Nicotine lozenge
- Nicotine patch
- Smartphone-delivered automated treatment
Nicotine lozenge is already approved in United States, Canada, European Union for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator